Skip to main navigation Skip to search Skip to main content

Corcept Therapeutics continues to outperform Pfizer by 40.4% year to date

Press/Media

Period22 Apr 2025

Media coverage

4

Media coverage

  • TitleCorcept Therapeutics continues to outperform Pfizer by 40.4% year to date
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date22/04/25
    PersonsMichael Murray
  • TitleCorcept Therapeutics continues to outperform Eli Lilly and Company by 18.9% year to date
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date22/04/25
    PersonsMichael Murray
  • TitleCorcept Therapeutics continues to outperform Johnson and Johnson by 16.3% year to date
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date22/04/25
    PersonsMichael Murray
  • TitleCorcept Therapeutics continues to outperform Merck by 46.6% year to date
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date22/04/25
    PersonsMichael Murray